
11 - 50 funcionários
Fundada em 2015
💊 Farmacêutico
🧬 Biotecnologia
Pharmaceuticals • Biotechnology
A Achieve Life Sciences é uma empresa farmacêutica especializada em fase avançada, focada no desenvolvimento de citisiniclina como tratamento para dependência de nicotina (cessação do tabagismo e vaping). A empresa está avançando com a citisiniclina através dos estudos ORCA Fase 2 e Fase 3 e submeteu um NDA; seu programa clínico visa os receptores nicotínicos para reduzir a abstinência e a satisfação do tabagismo, com o objetivo de oferecer uma nova opção de tratamento aprovada pela FDA para dependência de tabaco e nicotina.
🕒 Julho 27
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

11 - 50 funcionários
Fundada em 2015
💊 Farmacêutico
🧬 Biotecnologia
Pharmaceuticals • Biotechnology
A Achieve Life Sciences é uma empresa farmacêutica especializada em fase avançada, focada no desenvolvimento de citisiniclina como tratamento para dependência de nicotina (cessação do tabagismo e vaping). A empresa está avançando com a citisiniclina através dos estudos ORCA Fase 2 e Fase 3 e submeteu um NDA; seu programa clínico visa os receptores nicotínicos para reduzir a abstinência e a satisfação do tabagismo, com o objetivo de oferecer uma nova opção de tratamento aprovada pela FDA para dependência de tabaco e nicotina.
• Developing and leading the market access contracting strategy for cytisinicline, ensuring alignment with the Company’s overall commercial launch strategy and access objectives across Medicaid and Commercial payer channels. • Developing and executing contracting strategy for Medicaid channels, ensuring compliance with government pricing regulations and alignment with access goals. • Developing and executing contracting strategy for Commercial payers, including negotiation approach, pricing and rebate structures, and value-based contracting opportunities where appropriate. • Leading market research initiatives to inform contracting strategy, analyzing payer landscape dynamics, competitive contracting approaches, and access barriers to shape a data-driven approach to payer negotiations. • Building and managing robust, detailed timelines for payer discussions and contracting activities spanning pre-approval preparation through post-approval execution, ensuring readiness for launch. • Supporting engagement with key payers, incorporating payer feedback and contracting insights into the broader market access and launch strategy. • Defining and tracking key performance indicators for contracting outcomes, ensuring accountability to launch timelines and access targets. • Collaborating with Legal and Compliance to ensure all contracting activities adhere to regulatory standards, government pricing requirements, and corporate policies. • Recruiting, leading, and developing the contracting teams needed to support launch readiness across both Medicaid and Commercial channels, fostering a high-performing, collaborative culture. • Partnering with HEOR, Medical Affairs, Legal, and Commercial Operations to ensure contracting strategy reflects a compelling value proposition and supports the broader market access strategy.
• Bachelor’s degree in science, business, or a related discipline; an advanced degree such as an MBA is preferred. • At least 10 years of market access, contracting, or related commercial experience in the biopharmaceutical industry, with a preference for candidates with a minimum of 3 years of oncology, rare disease, or other specialty therapeutic area experience, and expertise in payer contracting, pricing, and reimbursement. • In-depth knowledge of the U.S. payer landscape across Medicaid and Commercial channels, including government pricing requirements.
• medical, dental, and vision insurance • a 401(k) retirement plan • participation in the Employee Stock Purchase Plan • company-paid life insurance and short- and long-term disability coverage • paid time off • paid company holidays
Candidatar-se🕒 Julho 27
Senior Director driving commercial insights and analytics for OptimizeRx, a healthcare technology leader. Collaborating with clients and stakeholders to enhance program efficacy and innovative solutions.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $140.000 - $150.000 / ano
💰 $9.000.000 Post-IPO Equity - OPTIMIZERx em 2018-05
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
🇺🇸 Estados Unidos – Remoto (EUA)
💰 Private Equity Round - Rimkus em 2024-02
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
Lead the strategic development and execution of the field medical organization for cell therapy. Shape field medical strategy and build relationships with KOLs and clinical investigators.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
Senior Director of Analytical Development overseeing analytical development for biological drug products. Collaborating with cross-functional teams for regulatory compliance and operational efficiency.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $250.000 - $280.000 / ano
💰 $111.828.793 Series A - Syncromune em 2024-12
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
Associate Director overseeing analytical strategy for drug and product development across clinical phases. Responsible for compliance with regulatory requirements and leading cross-functional collaboration.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $165.000 - $200.000 / ano
💰 $111.828.793 Series A - Syncromune em 2024-12
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🗣️🇨🇳 Chinês obrigatório